<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> is the precancerous lesion leading to Barrett <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>The natural history of Barrett <z:mpath ids='MPATH_160'>metaplasia</z:mpath> and its <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">neoplastic progression</z:e> are still controversial </plain></SENT>
<SENT sid="2" pm="."><plain>Anterior gradient 2 is up-regulated in both Barrett <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> and Barrett <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, but no information is available on anterior gradient 2 expression in the spectrum of the phenotypic changes occurring in the natural history of Barrett <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (<z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> cardiac-type <z:mpath ids='MPATH_160'>metaplasia</z:mpath>, <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath>, low-grade intraepithelial <z:hpo ids='HP_0002664'>neoplasia</z:hpo> [formerly called low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>], and high-grade intraepithelial <z:hpo ids='HP_0002664'>neoplasia</z:hpo> [formerly called high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>]) </plain></SENT>
<SENT sid="3" pm="."><plain>Applying immunohistochemistry and reverse transcription and quantitative real-time polymerase chain reaction, this study addressed the role of anterior gradient 2 in Barrett <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Anterior gradient 2 expression was assessed semiquantitatively in 125 consecutive biopsy samples in the <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> spectrum arising in <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> (<z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> cardiac-type <z:mpath ids='MPATH_160'>metaplasia</z:mpath>, 25; <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath>, 25; low-grade intraepithelial <z:hpo ids='HP_0002664'>neoplasia</z:hpo>, 25; high-grade intraepithelial <z:hpo ids='HP_0002664'>neoplasia</z:hpo>, 25; Barrett <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, 25) </plain></SENT>
<SENT sid="5" pm="."><plain>Additional biopsy samples of esophageal squamous mucosa (n=25) served as controls </plain></SENT>
<SENT sid="6" pm="."><plain>Anterior gradient 2 messenger <z:chebi fb="40" ids="33697">RNA</z:chebi> expression was also tested (reverse transcription and quantitative real-time polymerase chain reaction) in a different series of 40 samples (esophageal squamous mucosa, 10; <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> cardiac-type <z:mpath ids='MPATH_160'>metaplasia</z:mpath>, 10; <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath>, 10; Barrett <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, 10) </plain></SENT>
<SENT sid="7" pm="."><plain>Anterior gradient 2 was never expressed in squamous esophageal epithelium but consistently overexpressed (to much the same degree) in the whole spectrum of Barrett disease (<z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> cardiac-type <z:mpath ids='MPATH_160'>metaplasia</z:mpath>, <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath>, low-grade intraepithelial <z:hpo ids='HP_0002664'>neoplasia</z:hpo>, high-grade intraepithelial <z:hpo ids='HP_0002664'>neoplasia</z:hpo>, and Barrett <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>) </plain></SENT>
<SENT sid="8" pm="."><plain>Anterior gradient 2 messenger <z:chebi fb="40" ids="33697">RNA</z:chebi> was expressed significantly more in <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> cardiac-type <z:mpath ids='MPATH_160'>metaplasia</z:mpath>, <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath>, and Barrett <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> than in native squamous epithelium (P&lt;.001), with no significant differences between the 3 groups </plain></SENT>
<SENT sid="9" pm="."><plain>Anterior gradient 2 overexpression affects the whole spectrum of the metaplastic/neoplastic lesions involved in Barrett <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>This study supports the biological similarity of the nonintestinal and intestinal types of Barrett <z:mpath ids='MPATH_160'>metaplasia</z:mpath> as precursors of Barrett <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
</text></document>